Scientific Instruments Australia

AdAlta, located in Bundoora, Victoria, is a clinical-stage biotechnology company focused on developing next-generation cell and protein therapeutics for life-threatening diseases, particularly solid cancers. The company's innovative East to West strategy combines Asia's advancements in T-cell therapy with Australia's high-quality clinical and manufacturing capabilities. Among its notable projects, AdAlta's AD214 represents a novel approach to treating fibrotic diseases, while WD34 aims to offer a breakthrough treatment against malaria. The company is actively seeking strategic and financial partnerships to advance its research and development initiatives into clinical trials. Generated from the website